From accelerating the identification and
validation of novel therapeutic targets, to creating better animal models of human diseases in a shorter time frame, to reducing the number of failed products, Crispr looks set to shave millions off R&D costs and boost drug discovery, she says.
CellR4 is particularly interested in therapies and diagnostics, including all aspects of translation from bench to bedside: identification
of novel therapeutic targets, epidemiology, clinical trials, drug safety, and meta - analyses.
His current research focuses on inducible negative feedback regulation of inflammation, which provides novel insights into the tight regulation of inflammation and may lead to the identification
of novel therapeutic targets.